Eligible Cases

Post-Settlement Funding for Yaz/Yasmin Lawsuits

Bayer has recently settled over 1,800 of the Yaz and Yasmin  cases for approximately $402 million. In addition, according to the federally  appointed mediator working on the cases, an additional 7,500 suits are expected  to be settled by year’s end.

Hopefully this is a good indication of many future  settlements down the road. If you are an attorney or plaintiff with Yaz/Yasmin settlements  that are slow to pay out, RD Legal Funding can convert your unpaid legal  receivables into immediate cash. Simply fill out the brief application to your  right to schedule a consultation with one of our legal funding specialists.About Yaz/YasminYaz and Yasmin, manufactured by Bayer, are birth control  pills that contain the drug drospirenone. Birth control pills work by combining  estrogen and progestin to alter women’s hormone levels. However, birth control  pills made in the 1960’s using high levels of estrogen have been proven to  cause elevated risks of stroke.

Yasmin and Yaz, approved by the FDA in 2001 and 2006,  respectively, combined drospirenone (a new synthetic form of progestin) with  smaller amounts of estrogen than other products on the market. In 2010, Yaz  became the top selling birth control pill in the United States, generating  $1.58 billion in sales. This can be attributed in part to multi-million dollar  ad campaigns marketing the drug to women under the age of 35 as the birth  control pill that also combatted premenstrual depression and acne.

A 2011 study by Danish scientists, which was published in  the New England Journal of Medicine, found  that women taking drospirenone containing birth control pills suffered strokes  and heart attacks between 1.5 and 2 times more often than women not using  hormonal contraception. In April of 2012, the FDA began requiring the labels of  drospirenone containing birth control pills to display warnings of higher risk  of blood clots. Other brand name drospirenone pills include Beyaz (a generic  form of Yasmin distributed by Teva Pharmaceuticals) and Ocella (manufactured by  Bayer).

In addition to an increased risk for blood clots and  strokes, Yaz and Yasmin have been linked to an increased risk of venous  thromboembolism, pulmonary embolism, deep vein thrombosis, and heart attacks. There  are currently several thousand lawsuits against Bayer. The suits allege the  manufacturer failed to provide adequate warning about these potentially fatal  side effects.

A deep vein thrombosis is a blood clot that occurs in the  deep veins of the legs or pelvis. A pulmonary embolism occurs when a blood clot  breaks off, travels through the blood stream, and becomes lodged near the lung.  October 2010 court records indicate that of the cases filed up to that time,  approximately 40-41% involved a deep vein thrombosis or pulmonary embolism; 10%  involved a heart attack or stroke from Yaz; and about 43% involved claims for  gallbladder injury associated with Yaz.Accelerate Your  Yaz/Yasmin Legal FeesRD Legal Funding is prepared to provide  attorneys and the clients they represent with settlement financing on any  slow-paying Yaz/Yasmin settlements. Since 1998, RD Legal Funding has been a  leading provider of post-settlement cash flow solutions. If you would like to  accelerate the payment of any settled fees you are owed, please fill out the  brief application at the top of this page. If you would like to speak directly  with a legal funding specialist, please call RD Legal toll-free at  1-800-565-5177.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.